Discover why muted VIX levels may hide market risks, shifts in options strategies, and potential volatility plays in the ...
Not returns but trust is the key to capital market success: Sebi’s Tuhin Kanta Pandey to MF trustees
Sebi Chairman Tuhin Kanta Pandey emphasized that trust, not just returns, forms the foundation of India’s capital markets. He ...
Tata Capital share price made a weak debut on Indian stock market. The shares listed at 1 per cent premium over the IPO price ...
Bain Capital Specialty Finance trades near lows as BDC valuations look appealing despite sector risks and volatility. Find ...
For decades, private capital was a black box, reserved for a select few. Investments happened behind closed doors, data was ...
Monday, Oct. 13, will be a regular business day for United States stock markets, as markets will not close in observance of ...
Pradip Halder, Founder & CEO of PHD Capital, shares his insights on the Tata Capital IPO listing. According to him, investors should exercise caution and avoid rushing into this stock immediately. He ...
ET Now on MSN
Tata Capital Listing Today: Big Debut or Flat Start? | IPO Listing Day Analysis | Share Market Today
Big Debut or Flat Start? | IPO Listing Day Analysis | Share Market TodayTata Capital hits the stock market today! All eyes are on its much-awaited listing — will it open with strong gains or see a ...
Tata Capital IPO is set to make its grand debut on NSE and BSE on October 13, following its 1.95 times subscription and share ...
The shares opened at Rs 330 on listing day, roughly 1% above the IPO price of Rs 326—a flat, polite start for what was billed as the biggest public issue of the year.
Nuclear energy has become an adjacent opportunity alongside the artificial intelligence (AI) infrastructure boom.
Mirador Therapeutics has raised $400mn in one of the largest biotech deals this year, increasing hopes of boosting investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results